Stock listing
NASDAQ:NYXH Nyxoah SA Stock
US listing (NASDAQ) of Nyxoah SA · home listing Euronext:NYXH
Follow Nyxoah SA into a list and get an email when it puts out news.
Share price · NASDAQ:NYXH
$0.805 USD -0.054 (-6.3%)
Close on Nov 20, 2026
- Day range
- $0.800 – $0.850 USDNov 20, 2026
- Volume
- 97,550 sharesNov 20, 2026
- Market cap
- $81.98M USDAt the close on Nov 20, 2026 · price × 101.8M shares outstanding
- 52-week range
- $0.800 – $5.390 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $482,924 USDMedian day 168,600 shares · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:NYXH · Home | €0.748 EUR | -0.041 (-5.2%) | 168,928 | €0.810 | €0.810 | €0.740 | €0.789 | Close on Nov 20, 2026 |
| NASDAQ:NYXH | $0.805 USD | -0.054 (-6.3%) | 97,550 | $0.850 | $0.850 | $0.800 | $0.859 | Close on Nov 20, 2026 |
| Frankfurt:5YI | €0.741 EUR | -0.028 (-3.6%) | — | €0.780 | €0.780 | €0.741 | €0.769 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · NASDAQ:NYXH · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.846 | +0.035 | +4.3% | $0.830 | $0.854 | $0.800 | 262,100 | |
| $0.811 | -0.048 | -5.6% | $0.880 | $0.880 | $0.800 | 213,400 | |
| $0.859 | -0.011 | -1.3% | $0.897 | $0.919 | $0.859 | 321,300 | |
| $0.870 | -0.010 | -1.1% | $0.880 | $0.909 | $0.864 | 173,100 | |
| $0.880 | +0.008 | +0.9% | $0.880 | $0.897 | $0.858 | 91,900 | |
| $0.872 | -0.016 | -1.8% | $0.877 | $0.930 | $0.870 | 157,800 | |
| $0.888 | -0.012 | -1.3% | $0.924 | $0.930 | $0.880 | 178,800 | |
| $0.900 | -0.011 | -1.2% | $0.946 | $0.974 | $0.896 | 586,500 | |
| $0.911 | +0.055 | +6.4% | $0.930 | $0.930 | $0.891 | 295,900 | |
| $0.856 | +0.022 | +2.6% | $0.841 | $0.858 | $0.813 | 232,400 | |
| $0.834 | +0.012 | +1.5% | $0.863 | $0.868 | $0.800 | 181,000 | |
| $0.822 | -0.073 | -8.2% | $0.850 | $0.862 | $0.801 | 643,700 | |
| $0.895 | -0.045 | -4.8% | $0.920 | $0.945 | $0.879 | 413,400 | |
| $0.940 | -0.014 | -1.5% | $0.947 | $0.960 | $0.917 | 469,000 | |
| $0.954 | -0.156 | -14.1% | $0.964 | $0.970 | $0.900 | 484,200 | |
| $1.110 | -0.080 | -6.7% | $1.190 | $1.195 | $1.110 | 210,200 | |
| $1.190 | -0.060 | -4.8% | $1.200 | $1.220 | $1.190 | 131,300 | |
| $1.250 | -0.030 | -2.3% | $1.270 | $1.270 | $1.235 | 91,600 | |
| $1.280 | -0.030 | -2.3% | $1.310 | $1.320 | $1.280 | 58,600 | |
| $1.310 | -0.050 | -3.7% | $1.350 | $1.350 | $1.300 | 144,500 | |
| $1.360 | +0.010 | +0.7% | $1.350 | $1.379 | $1.350 | 36,100 | |
| $1.350 | -0.070 | -4.9% | $1.380 | $1.385 | $1.330 | 87,900 | |
| $1.420 | -0.010 | -0.7% | $1.420 | $1.450 | $1.410 | 81,500 | |
| $1.430 | +0.020 | +1.4% | $1.430 | $1.470 | $1.400 | 132,400 | |
| $1.410 | +0.050 | +3.7% | $1.370 | $1.465 | $1.360 | 191,300 | |
| $1.360 | +0.030 | +2.3% | $1.340 | $1.360 | $1.320 | 68,500 | |
| $1.330 | -0.050 | -3.6% | $1.380 | $1.380 | $1.310 | 120,800 | |
| $1.380 | +0.010 | +0.7% | $1.400 | $1.410 | $1.360 | 189,800 | |
| $1.370 | -0.220 | -13.8% | $1.510 | $1.510 | $1.370 | 337,300 | |
| $1.590 | +0.140 | +9.7% | $1.605 | $1.670 | $1.555 | 642,600 | |
| $1.450 | +0.180 | +14.2% | $1.340 | $1.470 | $1.340 | 264,100 | |
| $1.270 | -0.060 | -4.5% | $1.300 | $1.320 | $1.270 | 183,800 | |
| $1.330 | -0.070 | -5.0% | $1.400 | $1.405 | $1.300 | 257,800 | |
| $1.400 | -0.080 | -5.4% | $1.460 | $1.460 | $1.390 | 149,100 | |
| $1.480 | 0.000 | 0.0% | $1.500 | $1.500 | $1.460 | 59,800 | |
| $1.480 | -0.010 | -0.7% | $1.500 | $1.510 | $1.470 | 81,000 | |
| $1.490 | -0.060 | -3.9% | $1.560 | $1.560 | $1.480 | 74,400 | |
| $1.550 | +0.010 | +0.6% | $1.560 | $1.580 | $1.530 | 152,900 | |
| $1.540 | -0.060 | -3.8% | $1.580 | $1.580 | $1.530 | 64,300 | |
| $1.600 | +0.060 | +3.9% | $1.550 | $1.620 | $1.540 | 154,300 | |
| $1.540 | +0.040 | +2.7% | $1.540 | $1.570 | $1.510 | 179,300 | |
| $1.500 | -0.020 | -1.3% | $1.510 | $1.525 | $1.470 | 185,200 | |
| $1.520 | -0.040 | -2.6% | $1.560 | $1.560 | $1.505 | 237,800 | |
| $1.560 | -0.060 | -3.7% | $1.630 | $1.635 | $1.540 | 373,700 | |
| $1.620 | -0.140 | -8.0% | $1.740 | $1.810 | $1.590 | 1,004,900 | |
| $1.760 | +0.250 | +16.6% | $1.820 | $1.830 | $1.650 | 4,585,600 | |
| $1.510 | +0.020 | +1.3% | $1.520 | $1.535 | $1.495 | 3,029,000 | |
| $1.490 | -0.070 | -4.5% | $1.540 | $1.542 | $1.490 | 79,700 | |
| $1.560 | -0.040 | -2.5% | $1.620 | $1.620 | $1.550 | 105,900 | |
| $1.600 | +0.030 | +1.9% | $1.590 | $1.630 | $1.570 | 86,000 | |
| $1.570 | -0.050 | -3.1% | $1.640 | $1.640 | $1.570 | 100,900 | |
| $1.620 | -0.020 | -1.2% | $1.680 | $1.680 | $1.600 | 126,400 | |
| $1.640 | +0.020 | +1.2% | $1.630 | $1.660 | $1.605 | 156,700 | |
| $1.620 | +0.020 | +1.3% | $1.670 | $1.670 | $1.590 | 108,600 | |
| $1.600 | -0.040 | -2.4% | $1.640 | $1.650 | $1.585 | 164,100 | |
| $1.640 | -0.010 | -0.6% | $1.640 | $1.695 | $1.640 | 39,200 |
- Ticker
- NASDAQ:NYXH
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 28, 2026
Nyxoah Appoints Liam Kelly as Chief Executive Officer
Latest earnings call · Nov 5, 2026
Nyxoah (Euronext:NYXH) Q3 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 32 slides
Calls
Replays
Nyxoah (Euronext:NYXH) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Watch TranscriptNyxoah (Euronext:NYXH) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptNyxoah (Euronext:NYXH) Q1 2026 Earnings Call
Tue, May 12, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Nyxoah Appoints Liam Kelly as Chief Executive Officer
Sep 28, 2026
Closed $1.37 (-13.8%) on Sep 29, 2026
Nyxoah Announces Chief Financial Officer Transition
Sep 21, 2026
Closed $1.40 (-5.4%) on Sep 22, 2026
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
Sep 7, 2026
Closed $1.56 (-3.7%) on Sep 8, 2026
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
Sep 2, 2026
Closed $1.76 (+16.6%) on Sep 3, 2026
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results
Aug 5, 2026
Closed $1.31 (-7.1%) on Aug 6, 2026
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
Jul 27, 2026
Closed $1.43 (+2.1%) on Jul 28, 2026
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
Jul 7, 2026
Closed $1.67 (-0.6%) on Jul 8, 2026
Nyxoah to Host Investor Day in New York on July 8, 2026
Jun 23, 2026
Closed $1.62 (+3.2%) on Jun 24, 2026
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
Jun 19, 2026
Closed $1.57 (-1.9%) on Jun 22, 2026
Nyxoah Receives $15 Million from the European Investment Bank
Jun 17, 2026
Closed $1.60 (+0.6%) on Jun 18, 2026
Financings
Public offering of equity financing
Jun 10, 2026
Closed: US$95M raised · US$1.72 a share · BofA Securities +2
Dealers: BofA Securities (lead), Bank Degroof Petercam SA/NV, B. Riley
Insiders: strong insider participation
Use of proceeds: Accelerate the U.S. commercialization of Genio
Private placement of new ordinary shares
Nov 14, 2025 · US$19.76M
Announced: €17M · €4 a share · Degroof Petercam
Dealers: Degroof Petercam (lead)
Buyers: Robert Taub; Jürgen Hambrecht; Daniel Wildman; Olivier Taelman; John Landry; Scott Holstine
Insiders: Chairman, independent directors, CEO, CFO and Chief Commercial Officer together subscribed to 356,250 new shares for EUR 1.425 million
Use of proceeds: US and international commercialization of Genio, clinical data, R&D, new technologies pipeline and general corporate purposes
Registered direct offering of new ordinary shares
Nov 14, 2025
Announced: about US$5.6M · US$4.6304 a share
Convertible bonds
Nov 14, 2025 · US$52.3M
Announced: up to €45M
Use of proceeds: US and international commercialization of Genio, clinical data, R&D, new technologies pipeline and general corporate purposes
Decks
Investor Presentation (September 2026)
Investor deck · 32 slides · September 2026
H1 2026 Earnings Presentation
Earnings · 37 slides · Aug 5, 2026
Q1 2026 Earnings Presentation
Earnings · 33 slides · May 12, 2026
Investor Presentation (September 2025)
Investor deck · 22 slides · September 2025
Nyxoah SA on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 34 in the last 12 months · 52 in all · newest Sep 28, 2026 · oldest 2025
- Calls
- 19 calls with a replay · 19 with a transcript · latest Nov 5, 2026
- Decks
- 16 decks · latest September 2026
Where Nyxoah SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:NYXH · Home listing | Euronext | Belgium | EUR |
| NASDAQ:NYXH · This page | NASDAQ | United States | USD |
| gettex:5YI | gettex | Germany | EUR |
| LS Exchange:A2QCWK | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2QCWK | Lang & Schwarz | Germany | EUR |
| BOATS:NYXH | BOATS | United States | USD |
| Stuttgart:5YI | Stuttgart | Germany | EUR |
| Aquis:NYXHB | Aquis | United Kingdom | EUR |
| Aquis:NYXHB | Aquis | United Kingdom | EUR |
| Dusseldorf:5YI | Dusseldorf | Germany | EUR |
| Frankfurt:5YI | Frankfurt | Germany | EUR |
| Munich:5YI | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Nyxoah SA.